Sensitization of Decitabine Combined with Paclitaxel on Proliferation Inhibition and Apoptosis Induction of Paclitaxel-resistant MCF-7 Cells
- VernacularTitle:地西他滨联合紫杉醇对耐药MCF-7细胞增殖抑制和诱导凋亡的增敏作用
- Author:
Min ZHANG
;
Jie SHEN
;
Haifeng ZHOU
;
Ningzhou GAO
;
Yunxuan ZHANG
;
Feng FU
;
Zhongjuan SONG
- Publication Type:Journal Article
- Keywords:
Decitabine;
Paclitaxel resistant;
MCF-7 cell line;
Proliferation inhibition;
Cell apoptosis
- From:
China Pharmacist
2016;19(9):1638-1640
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the anti-proliferation and apoptosis-inducing effects of decitabine combined with paclitaxel on paclitaxel-resistant MCF-7 cells. Methods:Cell counting kit-8 (CCK-8) assays were used to determine the proliferation inhibition of drugs at different concentrations in 24, 48 and 72h. The group was treated with decitabine, paclitaxel and the combination of the two drugs, respectively. The cell apoptosis rate was determined by flow cytometry after the treatment with the drugs at different concentra-tions in 48h. Results:The results of CCK-8 showed the combination group significantly inhibited the cell proliferation when compared with the single drug use group(P<0. 05), and the anti-proliferation value was in a dose-dependent manner in all groups. The apopto-sis values after the treatment with decitabine, paclitaxel and the combination in 48h was(20. 4 ± 1. 98)%,(21. 8 ± 3. 34)% and(70. 8 ± 8. 23)%,respectively. Conclusion:The proliferation inhibition and apoptosis induction are both increased significantly in the com-bination group. Synergistic effect of decitabine and paclitaxel is found in multidrug resistant breast cancer cell line MCF-7 in vitro.
